Literature DB >> 11078214

Differential regulation of the monocytic calcium-binding peptides macrophage-inhibiting factor related protein-8 (MRP8/S100A8) and allograft inflammatory factor-1 (AIF-1) following human traumatic brain injury.

R Beschorner1, S Engel, M Mittelbronn, D Adjodah, K Dietz, H J Schluesener, R Meyermann.   

Abstract

Intracellular calcium (Ca2+) has been shown to function as second messenger and to be associated with activation of different cell types including microglia. Previously, in human focal cerebral infarctions an early expression of macrophage-related protein-8 (MRP8/ S100A8), a member of the Ca2+-binding S100-protein family, in microglia has been reported. On the other hand, a delayed activation of microglia was observed following traumatic brain injury (TBI). We therefore examined immunohistochemically microglial expression of MRP8 and allograft inflammatory factor-1 (AIF-1), identical to microglial response factor-1 (mrf-1) and ionized calcium binding adaptor molecule-1 (ibal) in human brains after TBI and in control brains. Both, MRP8 and AIF-1 are Ca2+-binding peptides which have been associated with microglial activation in experimental models and in human cerebral infarctions. Detection of AIF-1 in controls confirmed constitutive expression of this peptide in a subset of microglial cells. After TBI, the density of AIF-1+ microglia did not increase significantly. Lesional expression of AIF-1 did not significantly differ from other brain regions. Furthermore, following TBI, we found no significant differences in the density of AIF-1+ microglia as compared to controls. Microglial MRP8 expression was not detectable in controls and within the first 3 days post TBI, but increased rapidly after 3 days post TBI, suggesting a subpopulation of microglial cells to be AIF-1-/MRP8+. We conclude that the delayed expression of MRP8 and the lack of AIF-1 up-regulation in microglia after TBI is in contrast to ischemic brain lesions and might reflect different activation cascades of microglia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11078214      PMCID: PMC7086568          DOI: 10.1007/s004010000232

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  6 in total

1.  Acid Sphingomyelinase Inhibition Mitigates Histopathological and Behavioral Changes in a Murine Model of Traumatic Brain Injury.

Authors:  Grace M Niziolek; Ryan M Boudreau; Jennifer Baker; Lou Ann Friend; Amy T Makley; Michael J Edwards; Erich Gulbins; Michael D Goodman
Journal:  J Neurotrauma       Date:  2020-05-04       Impact factor: 5.269

Review 2.  Cerebral microhemorrhages due to traumatic brain injury and their effects on the aging human brain.

Authors:  Andrei Irimia; John D Van Horn; Paul M Vespa
Journal:  Neurobiol Aging       Date:  2018-03-06       Impact factor: 4.673

3.  The genomic profile of the cerebral cortex after closed head injury in mice: effects of minocycline.

Authors:  Peter J Crack; Jodee Gould; Nicole Bye; Shelley Ross; Uğur Ali; Mark D Habgood; Cristina Morganti-Kossman; Norman R Saunders; Paul J Hertzog
Journal:  J Neural Transm (Vienna)       Date:  2008-11-19       Impact factor: 3.575

4.  Moderate hypothermia inhibits microglial activation after traumatic brain injury by modulating autophagy/apoptosis and the MyD88-dependent TLR4 signaling pathway.

Authors:  Fengchen Zhang; Haiping Dong; Tao Lv; Ke Jin; Yichao Jin; Xiaohua Zhang; Jiyao Jiang
Journal:  J Neuroinflammation       Date:  2018-09-20       Impact factor: 8.322

Review 5.  A Comparative Biology of Microglia Across Species.

Authors:  Kaushik Sharma; Kanchan Bisht; Ukpong B Eyo
Journal:  Front Cell Dev Biol       Date:  2021-04-01

6.  Older Age Results in Differential Gene Expression after Mild Traumatic Brain Injury and Is Linked to Imaging Differences at Acute Follow-up.

Authors:  Young-Eun Cho; Lawrence L Latour; Hyungsuk Kim; L Christine Turtzo; Anlys Olivera; Whitney S Livingston; Dan Wang; Christiana Martin; Chen Lai; Ann Cashion; Jessica Gill
Journal:  Front Aging Neurosci       Date:  2016-07-13       Impact factor: 5.750

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.